FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-09-0432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

LMTK3 Confers Chemo-Resistance in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Transcriptome Profiling of Cervical Cancer Cells Acquired Resistance to Cisplatin by Deep Sequencing

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

FEN1 Promotes Tumor Progression and Confers Cisplatin Resistance in Non-Small-Cell Lung Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy